Confidence dives as UK scraps drug pricing scheme

46 percent of companies expected to drop clinical trials...ok...so where do they go next...hmmm...China? BD

LONDON (Reuters) - Pharmaceutical companies have lost confidence in investing in Britain following a decision by the government to scrap a 50-year-old drug pricing mechanism, according to a survey released on Thursday.
Three-quarters of more than 100 drugmakers with British operations said they had little confidence in the current UK market environment and 83 percent expect the position to deteriorate in the coming 12 months. The clash comes at a difficult time for the global drugs industry, which faces a marked slowdown in sales growth and is already cutting jobs. Barker estimated some 8,000 jobs had gone or been announced to go in Britain in the last two or three years, out of a total workforce of around 70,000.